Canada markets closed

Dermata Therapeutics, Inc. (DRMAW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.0081-0.0002 (-2.41%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-8,689
-7,795
-9,611
-7,902
-3,237
-
Depreciation & amortization
-
-
-
0
0.322
1.355
Stock based compensation
978.056
522.082
930.325
1,905
0
-
Change in working capital
247.002
863.677
-153.576
289.551
-755.845
-
Accounts Payable
329.675
369.326
-18.543
410.969
-232.908
-
Other working capital
-7,464
-6,409
-8,834
-5,693
-4,029
-
Other non-cash items
-
-
-
14.126
97.104
872.715
Net cash provided by operating activites
-7,464
-6,409
-8,834
-5,693
-4,029
-
Cash flows from financing activities
Debt repayment
-
-
0
-556.482
-810.185
-776.169
Common stock issued
3,431
7,606
4,276
15,386
0
-
Common stock repurchased
0
-0.04
0
-1,000
0
-
Net cash used privided by (used for) financing activities
3,431
7,606
4,277
15,962
2,567
-
Net change in cash
-4,033
1,197
-4,558
10,268
-1,461
-
Cash at beginning of period
8,767
6,241
10,799
530.4
1,992
-
Cash at end of period
4,734
7,438
6,241
10,799
530.4
-
Free Cash Flow
Operating Cash Flow
-7,464
-6,409
-8,834
-5,693
-4,029
-
Free Cash Flow
-7,464
-6,409
-8,834
-5,693
-4,029
-